Involved in Determining susceptibility to Crohns Disease参与确定克罗恩病的易感因素课件.ppt

Involved in Determining susceptibility to Crohns Disease参与确定克罗恩病的易感因素课件.ppt

  1. 1、本文档共37页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Fistulas: abnormal connections between intestines and another area of the body Strictures: narrowing of intestine Some patients may need to remove the enitre colon with or without the rectum * * DRUG THERAPY Non Rx treatment of acute symptoms Diarrhea, gas Acetaminophen for mild pain (not NSAIDS!) Supplements Rx treatment of flares and for remission Antibiotics Aminosalicylates Corticosteroids Mercaptopurine Monoclonal Antibodies AMINOSALICYLATES Mild to moderate CD Active form: 5-ASA - anti-inflammatory First line therapy due to lower side effects Ex. Mesalazine, Sulfalazine CORTICOSTEROIDS Moderate to severe CD Anti-inflammatory Suppress inflammatory genes that are activated in chronic inflammatory diseases by reversing histone acetylation, among other mechanisms Used sparingly due to side effects Reduce ability to fight infection* Ex. Prednisone, Budesonide MERCAPTOPURINE Remission: duration of action is months Purine analogs Exact mechanism unknown Interference with nucleic acid metabolism in immunological sequence that follows antigenic stimulation Ex. Azathioprine, 6-MP TNF-α INHIBITORS Severe CD – unresponsive to other treatments Biologic therapies: Monoclonal Antibodies Anti-TNF-α antibodies bind to TNF-α to prevent binding and activation of TNF receptors (neutralisation) Inactivation down regulates inflammatory reactions of autoimmune diseases May cause apoptosis of TNF-α expressing activated T cells Treatment of fistulising disease (closing maintenance of closure) inflammation ANTI-TNF-α MONOCLONAL ANTIBODIES Infliximab (Remicade) Mouse-human chimeric antibody IV ONLY (clinic/hospital) Adalimumab (HUMIRA) Fully human antibody Subcutaneous injection ONLY (self) SURGERY Reserved for complications or when disease that resists treatment is confined to one removable location (bowel resection) Complications requiring surgery may include Hemorrhage Fistulas Abscesses Strictures Colon cancer Summary Crohn’s Disease is characterized by inflammation, swelling

文档评论(0)

a888118a + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档